{
	"symbol": "PRN",
	"name": "Profound Medical Corp.",
	"price": 10.61,
	"priceChange": 0.06,
	"percentChange": 0.56872,
	"exchangeName": "Toronto Stock Exchange",
	"exShortName": "TSX",
	"exchangeCode": "TSX",
	"marketPlace": null,
	"sector": "Healthcare",
	"industry": "Medical Equipment & Supplies",
	"volume": 5100,
	"openPrice": 10.41,
	"dayHigh": 10.66,
	"dayLow": 10.41,
	"MarketCap": 261661391,
	"MarketCapAllClasses": 259752270,
	"peRatio": "",
	"prevClose": 10.55,
	"dividendFrequency": null,
	"dividendYield": null,
	"dividendAmount": null,
	"dividendCurrency": null,
	"beta": 0.830083,
	"eps": null,
	"exDividendDate": "",
	"longDescription": "Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.",
	"fulldescription": "Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.",
	"website": "https://www.profoundmedical.com",
	"email": "info@profoundmedical.com",
	"phoneNumber": "+1 647 476-1350",
	"fullAddress": "2400 Skymark Avenue,Unit 6, Mississauga, ON, CA",
	"employees": "131",
	"shareOutStanding": 24661771,
	"totalDebtToEquity": 0.17,
	"totalSharesOutStanding": 24481835,
	"sharesESCROW": 0,
	"vwap": 10.5769607,
	"dividendPayDate": null,
	"weeks52high": 15.75,
	"weeks52low": 9.55,
	"alpha": 0.014021,
	"averageVolume10D": 6522,
	"averageVolume20D": 8609,
	"averageVolume30D": 8291,
	"averageVolume50D": 8539,
	"priceToBook": 4.9,
	"priceToCashFlow": -7.6,
	"returnOnEquity": -66,
	"returnOnAssets": -51.65,
	"day21MovingAvg": 10.932381,
	"day50MovingAvg": 10.6692,
	"day200MovingAvg": 11.44855,
	"dividend3Years": "",
	"dividend5Years": "",
	"datatype": "equity",
	"issueType": "CS",
	"close": 10.61,
	"qmdescription": "Surgical & Medical Apparatus",
	"__typename": "Company"
}